Obesity – Complete project material

[ad_1]

CHAPTER ONE

1.0 INTRODUCTION

1.1 OBESITY

Obesity can be defined as an excess of Body Fat (BF). There is no consensus on a cutoff point for excess fatness of overweight or obesity in children and adolescents. Obesity is now so common within the world’s population that it is beginning to replace undernutrition and infectious diseases as the most significant contributor to ill health. In particular, obesity is associated with diabetes mellitus, coronary heart disease, certain forms of cancer, and sleep-breathing disorders (Caterson and Gill, 2002).

Obesity is defined by a body-mass index (weight divided by square of the height) of 30 kg m–2 or greater, but this does not take into account the morbidity and mortality associated with more modest degrees of overweight, nor the detrimental effect of intra-abdominal fat (Chan, 1994). The global epidemic of obesity results from a combination of genetic susceptibility, increased availability of high-energy foods and decreased requirement for physical activity in modern society. Obesity should no longer be regarded simply as a cosmetic problem affecting certain individuals, but an epidemic that threatens global well-being  (Caterson and Gill, 2002).

Obesity causes or exacerbates many health problems, both independently and in association with other diseases. In particular, it is associated with the development of type 2 diabetes mellitus, coronary heart disease (CHD), an increased incidence of certain forms of cancer, respiratory complications (obstructive sleep apnoea) and osteoarthritis of large and small joints (Styne et al., 2005).

There are also several methods to measure the percentage of body fat. In research, techniques include underwater weighing (densitometry), multi-frequency bioelectrical impedance analysis (BIA) and magnetic resonance imaging (MRI). In the clinical environment, techniques such as body mass index (BMI), waist circumference, and skin fold thickness have been used extensively. Although, these methods are less accurate than research methods, they are satisfactory to identify risk (Caterson and Gill, 2002; Styne et al., 2005).

Table 1 – Cut-off points proposed by a WHO expert committee for the

classification of overweight

BMI* (kg m–2)

WHO classification

Popular description

<18.5

Underweight

Thin

18.5–24.9

_____

‘Healthy’, ‘normal’, ‘acceptable’

25.0–29.9

Grade 1 overweight

Overweight

30.0–39.9

Grade 2 overweight

Obesity

≥40.0

Grade 3 overweight

Morbid obesity

*BMI is the weight in kilograms divided by the square of the height in metres.

The data presented in Tables 1 and 2 reflect knowledge acquired largely from epidemiological studies in developed countries. Preliminary information from developing nations indicates that lower cut-off levels for both BMI and waist circumference (see Table 2) are necessary for certain populations who are at particular risk from comparatively modest degrees of overweight.

Source: Peter, 2000

Table 2 – Waist circumference predicts risk of metabolic complications

Increased risk

Substantially increased risk

Men

≥94 cm

≥102 cm

Women

≥88 cm

≥88 cm

Gender-specific waist circumferences are presented that denote ‘increased risk’ (level 1) and ‘substantially increased risk’ (level 2) of metabolic complications associated with obesity in Caucasians. Level 1 is intended to alert clinicians to potential risk for CHD whereas level 2 should initiate therapeutic action

Source: Peter, 2000

While BMI seems appropriate for differentiating adults, it may not be as useful in children because of their changing body shape as they progress through normal growth. In addition, BMI fails to distinguish between fat and fat-free mass (muscle and bone) and may exaggerate obesity in large muscular children (Eckel and Krauss, 1998). While health consequences of obesity are related to excess fatness, the ideal method of classification should be based on direct measurement of fatness. Although methods such as densitometry can be used in research practice, they are not feasible for clinical settings (Chan, 1994).

GET THE COMPLETE PROJECT»

Do you need help? Talk to us right now: (+234) 8111770269, 08111770269 (Call/WhatsApp). Email: [email protected]

IF YOU CAN’T FIND YOUR TOPIC, CLICK HERE TO HIRE A WRITER»

Disclaimer: This PDF Material Content is Developed by the copyright owner to Serve as a RESEARCH GUIDE for Students to Conduct Academic Research. You are allowed to use the original PDF Research Material Guide you will receive in the following ways: 1. As a source for additional understanding of the project topic. 2. As a source for ideas for you own academic research work (if properly referenced). 3. For PROPER paraphrasing ( see your school definition of plagiarism and acceptable paraphrase). 4. Direct citing ( if referenced properly). Thank you so much for your respect for the authors copyright. Do you need help? Talk to us right now: (+234) 8111770269, 08111770269 (Call/WhatsApp). Email: [email protected]

[ad_2]


Purchase Detail

Hello, we’re glad you stopped by, you can download the complete project materials to this project with Abstract, Chapters 1 – 5, References and Appendix (Questionaire, Charts, etc) for N4000 ($15) only, To pay with Paypal, Bitcoin or Ethereum; please click here to chat us up via Whatsapp.
You can also call 08111770269 or +2348059541956 to place an order or use the whatsapp button below to chat us up.
Bank details are stated below.

Bank: UBA
Account No: 1021412898
Account Name: Starnet Innovations Limited

The Blazingprojects Mobile App



Download and install the Blazingprojects Mobile App from Google Play to enjoy over 50,000 project topics and materials from 73 departments, completely offline (no internet needed) with the project topics updated Monthly, click here to install.

Read Previous

Design, Construction And Testing Of An Improved Casting Pouring Ladle – Complete project material

Read Next

Comparative Analysis Of Pipeborne Water And Other Sources Of Water For Human Consumption (Independence Layout Locality) – Complete project material